Posts by KCAS Bio

Biomarker Webinar webinars
Read article Biomarkers Roundtable: Practical Insights for LBA and Molecular Assays

THURSDAY, APRIL 2nd | 1:30PM EST Biomarkers can move a program forward fast. Or slow it down with rework. Biomarkers shape decisions from discovery through late-stage clinical trials. But the wrong assay plan can waste time, budget and samples. In this KCAS Bio roundtable, we share practical ways to align…

KCAS-blog-thumb_2026-02-RO Assay and TE Blogs
Read article From Preclinical to Clinical: Tracking Target Binding in Solid Tumor Therapy

At KCAS Bio, we supported a therapeutic monoclonal antibody for advanced solid tumors from non-human primate (NHP) toxicology through first-in-human (FIH) dose escalation into phase 2 expansion. This project combined receptor occupancy assays (ROA) by flow cytometry for cell-surface binding on monocytes, immunophenotyping (IPT) for activation markers, and…

GLP-2026-KCASBio News
Read article KCAS Bio’s Lyon Site Renews GLP Compliance with Level “A” Status

KCAS Bio is proud to announce that its EU site (Lyon, France) has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP), confirming its ability to deliver GLP-grade bioanalytical methods in support of preclinical studies. Our GLP test facility was granted a Level of compliance “A”, reinforcing KCAS Bio’s capability to…

ASMS May 31 - June 4

KCAS Bio will be attending the 74th Conference on Mass Spectrometry and Allied Topics (ASMS) in San Diego, California from May 31 – June 4, 2026. This event is a cornerstone in the field of mass spectrometry, bringing together experts, innovators, and visionaries to share advancements and explore the future…

ASGCT May 11 - May 15

KCAS Bio is exhibiting at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11th-15th, 2026, in Boston, MA. This event serves as a global hub for scientific discovery and collaboration, bringing together leaders and innovators in the field of gene and cell…

AAPS NBC May 11 - May 14

KCAS Bio will be exhibiting at the American Association of Pharmaceutical Scientists National Biotechnology Conference (AAPS NBC), taking place from May 11th to May 14th, 2026, in San Diego, California. Visit KCAS Bio at Booth #302 to engage with our experts, explore our cutting-edge bioanalysis solutions, and learn how we…

GlobalHarmonization_KCASBio Posters & Papers
Read article Cross-Site Validation of a 15-Color Spectral Cytometry Panel for Leukocyte Profiling

Discover in this white paper a global collaboration between KCAS Bio and its strategic partner, Crux Biolabs, to harmonize and validate a standardized 15-color spectral flow cytometry panel for pan-leukocyte profiling across multiple sites. If you have any questions about these services or any others offered by…

Biovaria_KCASBio April 27 - April 28

KCAS Bio will be attending BioVaria in Munich, on April 27-28, 2026. This event connects leading tech transfer professionals and academic innovators with start-ups and representatives from the global biotech and pharma industry. Supporting Biologics Drug Development KCAS Bio supports small and large molecule drug development across preclinical and…

InnovationForHealth_KCASBio March 26 - March 26

KCAS Bio will be attending Innovation for Health in Utrecht, March 26, 2026. This events brings together key players from the Life Sciences & Health ecosystem. Centered on the theme “Bridging the Gap – From Idea to Innovation & from Patent to Patient,” the conference fosters insight sharing, collaboration, and…

GermanBiotechDays_KCASBio April 21 - April 22

KCAS Bio will be attending German Biotech Days in Leipzig, on April 21–22, 2026. German Biotech Days (DBT) bring together entrepreneurs, scientists, and key partners from across the biotech ecosystem, including investors, funding institutions, policymakers, and public administration. Supporting Biologics Drug Development KCAS Bio supports small and large molecule…

NextGenBiomed_KCASBio March 24 - March 25

KCAS Bio will be attending NextGen Biomed 2026 in London, on March 24–25, 2026. NextGen Biomed is a long-standing, community-driven platform that brings together the biologics and immunotherapy ecosystem to foster interdisciplinary collaboration and knowledge sharing across the R&D lifecycle. Supporting Biologics Drug Development KCAS Bio supports biologics drug…

Venture Connect March 24 - March 25

KCAS Bio will be attending Venture Connect in Durham, North Carolina on March 24-25, 2026. This event Brings together 200+ venture firms and capital sources to hear cutting-edge innovation in multiple verticals, and build strategic relationships that drive fundraising and business development. Venture Connect is the Southeast’s premier capital and…